Buying Guides · Jul 26, 2026

What "Research Use Only" Actually Means

For research reference only. Not guidance for use in humans or animals.

Every product on this site carries the same line: supplied as a laboratory reagent for research use only, not for human or veterinary use. It appears often enough that it starts reading as boilerplate. It is not — it is the designation the entire category rests on, and it is worth understanding before you buy from anyone.

The designation

"Research use only" marks a substance supplied for laboratory investigation rather than for diagnosis or treatment. An RUO reagent has not been through the approval process that a medicine goes through, and no regulator has assessed it for safety or efficacy in humans.

The distinction is about what has been *established*, not merely what is intended. An approved drug product carries evidence generated through clinical trials, manufacturing under pharmaceutical quality systems, approved labelling, and a regulator's assessment. An RUO reagent carries none of that. It is a chemical of stated identity and stated purity, and nothing beyond.

What it looks like in Canada

Health Canada authorises drugs through the Food and Drugs Act. An authorised product carries a Drug Identification Number — a DIN — which appears on the label. No research peptide sold as an RUO reagent has one.

This has a straightforward consequence. Selling a peptide for human use without authorisation is an offence under the Act, regardless of how it is labelled. Health Canada has acted on this: its April 2026 advisory and the seizure action against a domestic peptide seller both turned on products being marketed for human use without authorisation.

RUO labelling reflects what a reagent actually is. It does not convert an unapproved substance into an approved one, and no supplier can tell you otherwise.

What it obliges

For a supplier, honestly applied, it means: state identity and purity, publish the analysis, and make no claim about what the compound does in a person. No therapeutic claims, no dosing guidance, no administration protocols, no testimonials describing personal use. A supplier drifting into any of those has stopped selling a reagent and started marketing an unapproved drug, whatever their footer says.

For a buyer, it means the material is characterised chemically and not clinically. Purity tells you what fraction of the vial is the named compound. It tells you nothing about safety, and there is no regulator standing behind it.

Why the claim-free suppliers are the better signal

This is counter-intuitive at first: the supplier who tells you least about what a compound does is usually the more careful one.

A supplier making therapeutic claims has taken on regulatory exposure that threatens their continued existence, which makes them a poor bet for a supply relationship. More practically, a supplier willing to invent claims about outcomes is not obviously unwilling to invent numbers about purity. The two kinds of carelessness travel together.

What is worth judging a supplier on instead: whether the certificate names the lot in your hand, whether the lab is real and independently verifiable, and whether they are straight about which lots they have actually tested. Those are checkable. Claims are not.

Nothing on this page is legal advice. If you are sourcing reagents in an institutional setting, your own compliance office governs.